The FDA granted a positive review for an acute myeloid leukemia drug trial, with initial dosing expected in 2025.

Two of the most common types of leukemias in adults are acute myeloid leukemia (AML ... a variety of signs or symptoms such ...

"While benzene is not intentionally being added to skin-care products ... According to the American Cancer Society, rates of acute myeloid leukemia (AML) have been found higher in those who ...

A multi-institutional team developed a chimeric antigen receptor (CAR) T cell-based strategy for specifically targeting AML cells in patients who relapsed following other treatments. The team ...

Aug. 21, 2024 — An international team of scientists has uncovered a mechanism by which acute myeloid leukemia (AML) cells sustain their growth. AML cells prevent the synthesis of proteins that ...

A team of scientists from The University of Texas Health Science Center at San Antonio (UT Health San Antonio) has identified ...

Acute myeloid leukemia is a type of cancer that starts inside bone marrow, the soft tissue inside bones that helps form blood cells. The cancer develops from myeloid blasts cells that would ...

A new study has unveiled when chronic myeloid leukemia, a type of cancer that affects the blood and bone marrow, arises in ...

More information: Bo-Han Wei et al, Annotation-free deep learning for predicting gene mutations from whole slide images of acute myeloid leukemia, npj Precision Oncology (2025). DOI: 10.1038 ...

The first patient with relapsed or refractory acute myeloid leukemia has been dosed with Annamycin plus Cytarabine in the global phase 3 MIRACLE trial. The first patient with relapsed or refractory ...